» Articles » PMID: 19787413

Fractional Photothermolysis--an Update

Overview
Journal Lasers Med Sci
Publisher Springer
Date 2009 Sep 30
PMID 19787413
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

The novel concept of non-ablative fractional photothermolysis was introduced to the market in 2003 as an answer to the need for effective, yet low risk, resurfacing techniques. Unlike conventional ablative and non-ablative lasers, fractional ablative and non-ablative photothermolysis treats only a fraction of the skin, leaving up to a maximum of 95% of the skin uninvolved. The undamaged surrounding tissue allows for a reservoir of viable tissue, permitting rapid epidermal repair. Non-ablative fractional photothermolysis is currently approved by the US Food and Drug Administration (FDA) for the treatment of pigmented lesions, periorbital rhytides, skin resurfacing, melasma and soft tissue coagulation, acne and surgical scars, and actinic keratoses. However, its off-label use is clearly more extended. In 2007 the concept was further developed, and ablative fractional photothermolysis was introduced, using an erbium yttrium aluminium garnet (Er: YAG) or carbon dioxide laser. These devices are FDA cleared to treat wrinkles, rhytides, furrows, fine lines, textural irregularities, pigmented lesions and vascular dyschromia. In this review we discuss the two concepts, their technical details and clinical indications, and we describe the current literature available.

Citing Articles

Prospective, Split-Face Randomized Clinical Trial Comparing Non-ablative Fractional Laser for Periorbital Photoaging in Different Age Groups.

Jia X, Zheng H, Huang L, Feng Y Aesthetic Plast Surg. 2025; .

PMID: 40064643 DOI: 10.1007/s00266-025-04733-y.


Efficacy and safety of lasers versus topical medications for acanthosis nigricans and pseudo-acanthosis nigricans treatment: a systematic review.

Ghane Y, Heidari N, Hosseini S, Heidari A, Pishraft-Sabet H, Eghbali S Lasers Med Sci. 2024; 39(1):44.

PMID: 38253899 DOI: 10.1007/s10103-024-03986-4.


Large area fractional laser treatment of mouse skin increases energy expenditure.

Salma N, Wang-Evers M, Karasik D, Yerevanian A, Downs H, Luo T iScience. 2024; 27(1):108677.

PMID: 38213618 PMC: 10783634. DOI: 10.1016/j.isci.2023.108677.


Using a Topical Formulation of Vitamin D for the Treatment of Vitiligo: A Systematic Review.

Al-Smadi K, Ali M, Alavi S, Jin X, Imran M, Leite-Silva V Cells. 2023; 12(19).

PMID: 37830601 PMC: 10572240. DOI: 10.3390/cells12192387.


Efficacy of Fractional Carbon Dioxide (CO) Laser versus Q-Switched Neodymium-Doped Yttrium Aluminum Garnet (Nd:YAG) and Potassium-Titanyl-Phosphate (KTP) Lasers in the Treatment of Acanthosis Nigricans.

Elmasry M, Khalil M, Badawi A, Zaki N, Fahim A Clin Cosmet Investig Dermatol. 2023; 16:705-715.

PMID: 36992970 PMC: 10042172. DOI: 10.2147/CCID.S401479.


References
1.
Tannous Z . Fractional resurfacing. Clin Dermatol. 2007; 25(5):480-6. DOI: 10.1016/j.clindermatol.2007.05.007. View

2.
Dierickx C, Khatri K, Tannous Z, Childs J, Cohen R, Erofeev A . Micro-fractional ablative skin resurfacing with two novel erbium laser systems. Lasers Surg Med. 2008; 40(2):113-23. DOI: 10.1002/lsm.20601. View

3.
Hantash B, Bedi V, Chan K, Zachary C . Ex vivo histological characterization of a novel ablative fractional resurfacing device. Lasers Surg Med. 2006; 39(2):87-95. DOI: 10.1002/lsm.20405. View

4.
Blankenship C, Alster T . Fractional photothermolysis of residual hemangioma. Dermatol Surg. 2008; 34(8):1112-4. DOI: 10.1111/j.1524-4725.2008.34221.x. View

5.
Behroozan D, Goldberg L, Dai T, Geronemus R, Friedman P . Fractional photothermolysis for the treatment of surgical scars: a case report. J Cosmet Laser Ther. 2006; 8(1):35-8. DOI: 10.1080/14764170600607251. View